D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea
· Delayed Price · Currency is KRW 95,900
-700 (-0.72%)
At close: Dec 5, 2025
D&D Pharmatech Market Cap
D&D Pharmatech has a market cap or net worth of 4.16 trillion as of December 5, 2025. Its market cap has increased by 816.50% in one year.
Market Cap
4.16T
Enterprise Value
4.13T
Revenue
8.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
95,900.00
Market Cap Chart
Since May 2, 2024, D&D Pharmatech's market cap has increased from 379.56B to 4.16T, an increase of 997.18%. That is a compound annual growth rate of 349.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 4,164.48B | 710.83% |
| Dec 30, 2024 | 513.61B | 35.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.96T |
| Celltrion | 40.11T |
| ALTEOGEN | 24.41T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.49T |
| Yuhan | 8,755.13B |
| LigaChem Biosciences | 6,753.15B |
| Peptron | 6,645.44B |